Our results indicate that a doxorubicin‐induced increase in TGFβ expression contributes to YAP‐dependent AXL induction in mesenchymal‐type lung cancer cells, suggesting that alterations in EMT lead to chemoresistance by enhancing YAP‐dependent survival gene responses. The gene discussed is TGFB1; the disease is lung carcinoma.